These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 27816363

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nasopharyngeal carcinoma with paranasal sinus invasion: the prognostic significance and the evidence-based study basis of its T-staging category according to the AJCC staging system.
    Tian L, Li YZ, Mo YX, Liu LZ, Xie CM, Liang XX, Gong X, Fan W.
    BMC Cancer; 2014 Nov 18; 14():832. PubMed ID: 25403714
    [Abstract] [Full Text] [Related]

  • 23. Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era.
    Qi F, Chen B, Wang J, Lin X, Qi S, Yang J, Zhou S, Wang S, Gui L, Fang H, Liu P, Song Y, Yang S, Li Y, Dong M.
    Leuk Lymphoma; 2019 Nov 18; 60(11):2679-2688. PubMed ID: 31298062
    [Abstract] [Full Text] [Related]

  • 24. A TNM Staging System for Nasal NK/T-Cell Lymphoma.
    Yan Z, Huang HQ, Wang XX, Gao Y, Zhang YJ, Bai B, Zhao W, Jiang WQ, Li ZM, Xia ZJ, Lin SX, Xie CM.
    PLoS One; 2015 Nov 18; 10(6):e0130984. PubMed ID: 26098892
    [Abstract] [Full Text] [Related]

  • 25. Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.
    Yang CW, Wang CW, Hong RL, Tsai CL, Yao M, Tang JL, Lin CW, Cheng AL, Kuo SH.
    J Radiat Res; 2017 Jan 18; 58(1):114-122. PubMed ID: 27534792
    [Abstract] [Full Text] [Related]

  • 26. Prognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract.
    Fang H, Jin J, Wang WH, Wang SL, Zhou LQ, Li YX.
    Leuk Lymphoma; 2014 Aug 18; 55(8):1832-7. PubMed ID: 24144309
    [Abstract] [Full Text] [Related]

  • 27. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Wan Y, Tian L, Zhang G, Xin H, Li H, Dong A, Liang Y, Jing B, Zhou J, Cui C, Chen M, Sun Y, Xie C, Liu L, Shao Y.
    Radiother Oncol; 2019 Feb 18; 131():35-44. PubMed ID: 30773185
    [Abstract] [Full Text] [Related]

  • 28. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging.
    Tang L, Mao Y, Liu L, Liang S, Chen Y, Sun Y, Liao X, Lin A, Liu M, Li L, Ma J.
    Cancer; 2009 Feb 01; 115(3):680-8. PubMed ID: 19117352
    [Abstract] [Full Text] [Related]

  • 29. Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation.
    Li WF, Sun Y, Chen M, Tang LL, Liu LZ, Mao YP, Chen L, Zhou GQ, Li L, Ma J.
    Chin J Cancer; 2012 Dec 01; 31(12):579-87. PubMed ID: 22854064
    [Abstract] [Full Text] [Related]

  • 30. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.
    Oral Oncol; 2008 Jan 01; 44(1):23-30. PubMed ID: 17306611
    [Abstract] [Full Text] [Related]

  • 31. Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature.
    Porte J, Hennequin C, Krizch D, Vercellino L, Guillerm S, Thieblemont C, Quéro L.
    Strahlenther Onkol; 2024 May 01; 200(5):434-443. PubMed ID: 37945929
    [Abstract] [Full Text] [Related]

  • 32. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
    Li WF, Sun Y, Mao YP, Chen L, Chen YY, Chen M, Liu LZ, Lin AH, Li L, Ma J.
    Int J Radiat Oncol Biol Phys; 2013 Jun 01; 86(2):249-56. PubMed ID: 23200171
    [Abstract] [Full Text] [Related]

  • 33. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF.
    Zhonghua Zhong Liu Za Zhi; 2006 Jan 01; 28(1):58-61. PubMed ID: 16737624
    [Abstract] [Full Text] [Related]

  • 37. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
    Wang L, Wang Z, Xia ZJ, Lu Y, Huang HQ, Zhang YJ.
    Tumour Biol; 2015 Sep 01; 36(10):7717-23. PubMed ID: 25935537
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic cervical lymph node irradiation provides no benefit for patients of stage IE extranodal natural killer/T cell lymphoma, nasal type.
    Wang L, Xia ZJ, Lu Y, Zhang YJ.
    Med Oncol; 2015 Jan 01; 32(1):320. PubMed ID: 25429828
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Malignomas of the nasal cavity and the paranasal sinuses: clinical characteristics, therapy and prognosis of different tumor types].
    Euteneuer S, Sudhoff H, Bernal-Sprekelsen M, Theegarten D, Dazert S.
    Laryngorhinootologie; 2004 Jan 01; 83(1):33-9. PubMed ID: 14740304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.